| Literature DB >> 32206301 |
Jin Wang1, Yu-Ting Wang2, Yan Fang3, Yan-Li Lu3, Ming-Xue Li3.
Abstract
In this article, three organotin complexes formulated as [(Me)2Sn(H2L1)] (1), [(Ph)2Sn(H2L1)]·MeOH (2) and [(Me)2Sn(HL2)(OAc)]4(Me)2O (3) (H4L1 = bis(2-hydroxybenzaldehyde) thiocarbohydrazone and H2L2 = bis(2-acetylpyrazine) thiocarbonohydrazone) have been synthesized and structurally characterized. Growth inhibition assays indicated that both the proligands and the three complexes are capable of showing anticancer activity against the human hepatocellular carcinoma HepG2 cells with H2L2 and complex 3 showing much higher cytotoxic potential. Subsequent toxicity studies on normal QSG7701cells showed that complex 3 has the highest tumor cell selectivity, and its IC50 value on QSG7701 cells is 8.48 fold higher than that in HepG2 cells. In acute toxicity experiments, complex 3 produces a dose-dependent effect in NIH mice with a LD50 value of 17.2 mg kg-1. This journal is © The Royal Society of Chemistry 2019.Entities:
Year: 2019 PMID: 32206301 PMCID: PMC7069364 DOI: 10.1039/c9tx00109c
Source DB: PubMed Journal: Toxicol Res (Camb) ISSN: 2045-452X Impact factor: 3.524